USPTO 2015–2025 USPTO PatentsView Foreign Corporation

GLYCOM A/S

USPTO PatentsView assignee record — 88 granted patents across 24 technology areas, active 2015–2025. Filing-trend and competitive-moat analysis cross-referenced to USPTO Patent Public Search. Primary class: A61K (PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES).

88
Total patents granted
24
CPC technology areas
16.7
Avg claims per patent
+200%
5-year filing velocity

Portfolio overview

GLYCOM A/S has been granted 88 US utility patents between 2015 and 2025, placing GLYCOM A/S at rank #4,082 across all assignees tracked by PlainPatent. This portfolio spans 24 distinct Cooperative Patent Classification (CPC) subclasses, averaging 16.7 claims per patent with primary concentration in A61K (PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES). As a Foreign Corporation, GLYCOM A/S is one of the more focused assignees in the PatentsView dataset. The composite Innovation Score of 51.5/100 blends portfolio volume, filing velocity, technology breadth, and claim depth into a single comparable measure drawn directly from USPTO PatentsView records.

Filing cadence tells the strategic story. Between 2020 and 2025 the company received 66 grants, compared with 22 in the 2015–2019 window — a +200% shift in five-year velocity. An acceleration of this magnitude signals aggressive R&D investment and expanding technical ambition. The Foreign Corporation classification further shapes interpretation, since corporate, government, and individual filers pursue patents for materially different reasons.

Claim depth and technology breadth together indicate competitive posture. GLYCOM A/S's 16.7 average claims per patent sits within the typical range for solid legal coverage without excessive prosecution cost, while a multi-domain presence across 24 subclasses balances depth with breadth. Combined with portfolio volume, these signals let analysts, investors, and licensing professionals benchmark GLYCOM A/S against peers pursuing similar technology classes.

How does GLYCOM compare?

Granted US patents 2015–2025 versus the largest corporate holders — this company marked ◀

patents

What this shows GLYCOM holds 88 patents — placing it at rank #4,082 overall, well behind the volume leaders but ahead of the tens of thousands of smaller assignees in the dataset.

Source USPTO PatentsView — granted utility patents As of 2015–2025

USPTO utility patent grants by year · 2015–2025

05101520 20152016201720182019202020212022202320242025 4
USPTO utility patent grants by year · 2015–2025

Grants by year

Teal-shaded recent years (2020–present) versus the 2015–2019 baseline. Full figures in the table below.

View data table
GLYCOM A/S patent grants by year, 2015–2025
Year Patents Granted Share of Period
2015 5 5.7%
2016 3 3.4%
2017 3 3.4%
2018 4 4.5%
2019 7 8.0%
2020 14 15.9%
2021 9 10.2%
2022 17 19.3%
2023 10 11.4%
2024 12 13.6%
2025 4 4.5%

Patent Moat Analysis

Portfolio Volume Light
Tech Breadth Multi-domain
Claim Depth Standard
Velocity Accelerating

Where it ranks

Overall rank by patents

#4,082

Across all tracked assignees

Innovation Score

51.5 out of 100

View all rankings →

Data Source

USPTO PatentsView — US granted patents 2015–2025

How is Innovation Score calculated?

Frequently Asked Questions

How many patents does GLYCOM A/S hold?
GLYCOM A/S holds 88 US granted patents filed between 2015 and 2025, spanning 24 technology areas.
What is GLYCOM A/S's Innovation Score?
GLYCOM A/S has an Innovation Score of 51.5 out of 100. This composite metric weighs portfolio volume (40%), filing velocity (20%), technology breadth (25%), and claim depth (15%).
What technology areas does GLYCOM A/S focus on?
GLYCOM A/S's top technology area is A61K (PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES) with 51 patents. The company has filed patents in 24 CPC subclasses total.
Is GLYCOM A/S's patent filing rate increasing or decreasing?
GLYCOM A/S's recent filing velocity is +200% compared to the prior five-year period. This indicates accelerating innovation.
What does claim depth mean for GLYCOM A/S's patents?
GLYCOM A/S's patents average 16.7 claims each. This falls within the standard range, providing solid legal coverage.
How is the GLYCOM A/S patent data sourced?
All patent data comes from USPTO PatentsView, a public research dataset maintained by the United States Patent and Trademark Office covering US granted utility patents from 2015 to 2025.

Learn More

Explore the patent dataset

Data sourced from USPTO PatentsView — official U.S. government patent data. See our methodology for computation details. Retrieved and formatted by PlainPatent Editorial

Disclaimer: This information is provided for informational purposes only and does not constitute professional advice. Data is sourced from the USPTO PatentsView database. Consult a qualified professional before making decisions based on this data.

All federal data sources used on this page
  • USPTO PatentsView — official U.S. Patent and Trademark Office bulk patent data. patentsview.org
  • USPTO Patent Application Information Retrieval (PAIR) — application status and file history. uspto.gov/patents/pair
  • USPTO Bulk Data Storage System — comprehensive patent text + claims dataset. bulkdata.uspto.gov
  • USPTO CPC Classification — Cooperative Patent Classification scheme for technology categorization. uspto.gov/cpc
  • SEC EDGAR — public filings cross-reference for assignee corporate entity matching. sec.gov/edgar
  • WIPO PATENTSCOPE — international patent context (related international filings). wipo.int/patentscope